Cat DNA Test Comparison Reveals Major Discrepancies Among Top Brands

A freelance journalist collected saliva from two domestic cats, submitted the samples to three of the most heavily promoted cat DNA testing providers, and discovered that the resulting breed and health reports varied dramatically.

Genetic testing for pets has shifted from a fringe hobby to a widely embraced market, as owners seek insight into breed lineage, possible health hazards, and even temperament hints. Although DNA kits for dogs have existed for many years, those aimed at cats are a recent development, raising doubts about their accuracy.

For the test, the cat owner took oral swabs from both animals, sealed the specimens following each brand’s guidelines, and dispatched them to the corresponding labs. Each of the three companies employs its own proprietary genotyping array to examine a defined set of genetic markers, producing an electronic report that lists breed makeup, detected mutations, and risk evaluations for specific ailments.

The three reports differed markedly. One provider identified a pronounced Siamese ancestry in the tabby cat, a second classified it mainly as mixed domestic, while the third presented a mixture of several breeds but noted low confidence. The health sections were inconsistent as well: one analysis flagged a risk for hypertrophic cardiomyopathy, whereas the other two omitted that finding and instead pointed to possible food sensitivities.

Analysts in the sector attribute the disparity to the absence of uniform reference databases and to variations in the count of genetic markers each kit examines. In the absence of a common standard, every firm’s algorithm processes identical raw data differently, producing conflicting outcomes. Additionally, numerous intricate traits—like behavior or disease susceptibility—are governed by many genes and environmental influences, curbing the predictive capability of any solitary test.

Consumer watchdog groups recommend that pet owners view DNA test outcomes as a preliminary screening, not a conclusive diagnosis. Veterinarians can assist in interpreting any highlighted health issues and decide if additional clinical examinations are needed. As the industry grows, the price of kits—generally between $80 and $150—should be balanced against the tangible usefulness of the data supplied.

Future prospects include a number of firms revealing intentions to expand their genetic panels, add more breeds, and fine‑tune their analytical models. Yet regulatory supervision stays limited, and there are still no universal industry standards. Ongoing consumer interest is expected to spur competition and pressure for increased transparency, which may eventually enhance both the precision and utility of cat DNA testing for owners and veterinarians alike.